Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Cash flows from operating activities:
Net income	$ 14,198,719	$ (14,946,821)
Adjustments to reconcile net income to net cash used in operating activities:
Amortization (accretion) of investments	(49,401)	(98,297)
Realized investment gains (losses), net	(145,046)	117,000
Change in fair value of equity securities	(20,179,879)	17,392,937
Unrealized trading (gains) losses included in income	(2,734)	0
Realized trading (gains) losses included in income	(10,954)	0
Amortization of cost of insurance acquired	178,743	186,213
Depreciation and depletion	624,797	607,243
Stock-based compensation	153,765	201,549
Charges for mortality and administration of universal life and annuity products	(1,603,750)	(1,583,889)
Interest credited to account balances	987,251	1,009,012
Change in accrued investment income	122,188	296,495
Change in reinsurance receivables	413,486	37,201
Change in policy liabilities and accruals	(1,416,401)	(1,943,479)
Change in income taxes receivable (payable)	(1,216,970)	3,153,812
Change in other assets and liabilities, net	4,260,542	(9,630,253)
Net cash used in operating activities	(3,685,644)	(5,201,277)
Proceeds from investments sold and matured:
Fixed maturities available for sale	505,000	8,626,339
Equity securities	541,790	13,350,043
Trading securities	8,492	0
Mortgage loans	1,212,205	61,847
Real estate	589,785	669,251
Notes receivable	322,411	2,189,408
Policy loans	244,121	387,870
Short-term investments	0	3,000,000
Total proceeds from investments sold and matured	3,423,804	28,284,758
Cost of investments acquired:
Fixed maturities available for sale	(20,000)	(9,038,928)
Equity securities	(8,468,969)	(3,547,593)
Trading securities	(4,232)	0
Mortgage loans	(387,039)	(931,378)
Real estate	(780,781)	0
Notes receivable	0	(3,500,000)
Policy loans	(196,034)	(316,675)
Short-term investments	0	(7,890,228)
Total cost of investments acquired	(9,857,055)	(25,224,802)
Net cash provided by (used in) investing activities	(6,433,251)	3,059,956
Cash flows from financing activities:
Policyholder contract deposits	1,195,495	1,187,672
Policyholder contract withdrawals	(1,820,928)	(1,092,331)
Purchase of treasury stock	(112,856)	(310,603)
Non controlling contributions (distributions) of consolidated subsidiary	0	0
Net cash used in financing activities	(738,289)	(215,262)
Net increase (decrease) in cash and cash equivalents	(10,857,184)	(2,356,583)
Cash and cash equivalents at beginning of year	39,025,754	28,787,629
Cash and cash equivalents at end of year	$ 28,168,570	$ 26,431,046